You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API rosuvastatin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing rosuvastatin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 CELLULOSE, MICROCRYSTALLINE
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 FERRIC OXIDE YELLOW
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 HYPROMELLOSE
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 LACTOSE MONOHYDRATE
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 TITANIUM DIOXIDE
AstraZeneca Pharmaceuticals LP CRESTOR rosuvastatin 0310-7560 TRIACETIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing rosuvastatin

Company Ingredient NDC Excipient
Accord Healthcare Inc rosuvastatin 16729-284 ANHYDROUS LACTOSE
Accord Healthcare Inc rosuvastatin 16729-284 CELLULOSE, MICROCRYSTALLINE
Accord Healthcare Inc rosuvastatin 16729-284 CROSPOVIDONE
Accord Healthcare Inc rosuvastatin 16729-284 FERRIC OXIDE YELLOW
Accord Healthcare Inc rosuvastatin 16729-284 HYPROMELLOSES
Accord Healthcare Inc rosuvastatin 16729-284 LACTOSE MONOHYDRATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for rosuvastatin

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

rosuvastatin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
NCS HealthCare of KY LLC dba Vangard Labs rosuvastatin calcium 0615-8532
Tris Pharma Inc rosuvastatin calcium 27808-155
Tris Pharma Inc rosuvastatin calcium 27808-156
Solco Healthcare LLC rosuvastatin calcium 43547-591
A-S Medication Solutions rosuvastatin calcium 50090-2447
A-S Medication Solutions rosuvastatin calcium 50090-4710
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77891

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

rosuvastatin drug variants containing HYPROMELLOSE 2910

Company Ingredient NDC
NCS HealthCare of KY LLC dba Vangard Labs rosuvastatin calcium 0615-8532
Sandoz Inc rosuvastatin calcium 0781-5400
Major Pharmaceuticals rosuvastatin calcium 0904-6778
Torrent Pharmaceuticals Limited rosuvastatin calcium 13668-179
TORRENT PHARMACEUTICALS LIMITED rosuvastatin calcium 13668-720
TORRENT PHARMACEUTICALS LIMITED rosuvastatin calcium 13668-721
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM OXIDE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MEGLUMINE

rosuvastatin drug variants containing MEGLUMINE

Company Ingredient NDC
Shandong New Time Pharmaceutical Co Ltd rosuvastatin calcium 42677-301
A-S Medication Solutions rosuvastatin calcium 50090-5110
A-S Medication Solutions rosuvastatin calcium 50090-5770
A-S Medication Solutions rosuvastatin calcium 50090-5771
A-S Medication Solutions rosuvastatin calcium 50090-6519
A-S Medication Solutions rosuvastatin calcium 50090-6611
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 3500

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CARBONATE MONOHYDRATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIBASIC CALCIUM PHOSPHATE

rosuvastatin drug variants containing TRIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
AstraZeneca Pharmaceuticals LP rosuvastatin calcium 0310-7580
Aphena Pharma Solutions - Tennessee LLC rosuvastatin calcium 43353-290
A-S Medication Solutions rosuvastatin calcium 50090-1097
HJ Harkins Company Inc rosuvastatin calcium 52959-629
PD-Rx Pharmaceuticals Inc rosuvastatin calcium 55289-932
PD-Rx Pharmaceuticals Inc rosuvastatin calcium 55289-935
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group